News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
265 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37186)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (29156)
Month
January (3217)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (102)
4 (174)
5 (247)
6 (211)
7 (265)
8 (238)
11 (138)
12 (205)
13 (219)
14 (240)
15 (174)
18 (169)
19 (181)
20 (151)
21 (144)
22 (81)
23 (1)
25 (165)
26 (154)
27 (94)
28 (19)
29 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
4
5
6
7
8
11
12
13
14
15
18
19
20
21
22
23
25
26
27
28
29
Press Releases
Aclipse Therapeutics Selected to Present M102 ALS Clinical Development Program at Prestigious ALS and Motor Neurone Disease Symposia
November 7, 2024
·
3 min read
Press Releases
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 7, 2024
·
13 min read
Press Releases
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024
November 7, 2024
·
2 min read
Press Releases
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
November 7, 2024
·
7 min read
Press Releases
CervoMed to Participate in Upcoming Investor Conferences
November 7, 2024
·
1 min read
Press Releases
Ikena Oncology Reports Third Quarter 2024 Financial Results
November 7, 2024
·
4 min read
Press Releases
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
November 7, 2024
·
4 min read
Press Releases
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights
November 7, 2024
·
11 min read
Press Releases
Palisade Bio Announces First Subject Dosed in Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis (UC)
November 7, 2024
·
5 min read
Press Releases
Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations
November 7, 2024
·
8 min read
Previous
20 of 27
Next
